These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 17602426
1. Changes in serum prostate-specific antigen level after prostatectomy in patients with benign prostatic hyperplasia. Hosseini SY, Salimi M, Hosseini Moghaddam SM. Urol J; 2005; 2(4):183-8. PubMed ID: 17602426 [Abstract] [Full Text] [Related]
3. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. Marks LS, Dorey FJ, Rhodes T, Shery ED, Rittenhouse H, Partin AW, deKernion JB. J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302 [Abstract] [Full Text] [Related]
4. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT. Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074 [Abstract] [Full Text] [Related]
5. Altered prostate specific antigen reference range after transurethral resection of the prostate. Wolff JM, Boekels O, Borchers H, Jakse G, Rohde D. Anticancer Res; 2000 Jul; 20(6D):4977-80. PubMed ID: 11326651 [Abstract] [Full Text] [Related]
7. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy? Godoy G, Tareen BU, Lepor H. Urology; 2009 Jul; 74(1):167-70. PubMed ID: 19406457 [Abstract] [Full Text] [Related]
8. Prostate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophy. Shingleton WB, Terrell F, Kolski J, May W, Renfroe DL, Fowler JE. Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):200-202. PubMed ID: 12497098 [Abstract] [Full Text] [Related]
12. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level. van Renterghem K, Van Koeveringe G, Achten R, Van Kerrebroeck P. Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482 [Abstract] [Full Text] [Related]
14. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM. Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035 [Abstract] [Full Text] [Related]
16. [Histopathological characteristics of radical prostatectomy specimen and long-term PSA changes in men with PSA levels of 4.0 ng/ml or less]. Kanno H, Umemoto S, Izumi K, Hasumi H, Osada Y, Ohta J, Tuchiya F, Kuwao S. Hinyokika Kiyo; 2008 Mar; 54(3):207-15. PubMed ID: 18411777 [Abstract] [Full Text] [Related]
17. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate. Palisaar JR, Wenske S, Sommerer F, Hinkel A, Noldus J. BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408 [Abstract] [Full Text] [Related]